Al-Hendy A

No ORCID on file · 52 papers in corpus · active 2007-2026

Study types

  • review 9
  • article 7
  • other 5
  • preprint 1
  • rct 1

Condition tags

  • endometriosis 17
  • infertility 6
  • dysmenorrhea 3
  • dyspareunia 2
  • chronic_pelvic_pain 1
  • adenomyosis 1
review 2026
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2026.105642

Endometriosis is a chronic, systemic, oestrogen-dependent disease with major impacts on pain, fertility and quality of life. This Society of Endometriosis and Uterine Disorders and American Institute for Minimally Invasive Surgery opinion s…

other 2026
Environmental toxicology ·doi:10.1002/tox.70046

This study investigates how phthalate exposure contributes to uterine fibroid (UF) development by studying the effects of the Mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), a metabolite of Di(2-ethylhexyl) phthalate, on myometrial stem ce…

2025
Journal of women's health (2002) ·doi:10.1089/jwh.2024.0403

Objective: Early menarche is associated with uterine fibroid risk, but the association between menarcheal timing and fibroid severity remains to be explored. Given the hormonal dependence of fibroids, earlier menarche may increase physical …

rct 2025
Fertility and sterility ·doi:10.1016/j.fertnstert.2025.04.037

OBJECTIVE: To assess the effects of relugolix combination therapy in women with uterine fibroids (UFs) and concomitant ultrasound-diagnosed adenomyosis. DESIGN: This post hoc analysis used pooled data from completers of the pivotal LIBERTY…

2025
Clinical and translational science ·doi:10.1111/cts.70189

Previous epidemiological studies have suggested that green tea catechins, including Epigallocatechin-3-gallate (EGCG), the most abundant polyphenol in green tea, may be associated with reduced serum folate levels. This is of particular inte…

other 2025
Cell proliferation ·doi:10.1111/cpr.70025

Uterine fibroids (UFs) are the most common benign gynecologic tumours affecting women of reproductive age. This study aims to deepen the understanding of UFs complex aetiology through harnessing the power of 3D organoid models derived from …

review 2024
International journal of women's health ·doi:10.2147/ijwh.s442357

Current medical treatment options for endometriosis associated pains are inadequate. Evidence on effects of nonsteroidal anti-inflammatory drugs is scarce. Around one third of patients are not responsive to oral contraceptives or progestins…

article 2024

Essam R Othman,1,2 Ayman Al-Hendy,3 Radwa Mostafa,1 Cornelis B Lambalk,2 Velja Mijatovic2 1OB-GYN Department, Assiut University, Assiut, 71515, Egypt; 2Academic Endometriosis Center, Amsterdam University Medical Center, Vrije Universiteit A…

article 2023
Journal of endometriosis and uterine disorders ·doi:10.1016/j.jeud.2023.100018

• Uterine fibroids are the most common benign tumor to women of reproductive age with no clear pathomechanism. • Current medical therapies are designed to blunt the stimulatory effects of gonadal steroid hormones on uterine fibroids growth.…

2022
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-022-00877-3

Uterine fibroids are common benign tumors that occur in up to 80% of women. Approximately half of the women affected experience considerable physical, psychological, and economic burdens and impact on quality of life due to symptoms such as…

2022
Expert opinion on pharmacotherapy ·doi:10.1080/14656566.2022.2030705

IntroductionUterine Fibroids (UFs) are the most predominant benign tumor in women who are coming of reproductive age, and causes intense economic load priced in billions of US dollars. Historically, surgery has been the main definitive trea…

2022
Expert opinion on drug safety ·doi:10.1080/14740338.2022.1989409

IntroductionUterine fibroids (UFs) are the most prevalent benign neoplastic threat originating from myometria of reproductive age women, with a profound financial load valued in hundreds of billions of dollars. Unfortunately, there is no cu…

review 2022
Frontiers in cellular and infection microbiology ·doi:10.3389/fcimb.2022.1059825

Every year, millions of women are affected by genital tract disorders, such as bacterial vaginosis (BV), endometrial cancer, polycystic ovary syndrome (PCOS), endometriosis, and uterine fibroids (UFs). These disorders pose a significant eco…

2022
Obstetrics and gynecology ·doi:10.1097/aog.0000000000004988

ObjectiveIn the LIBERTY 1 and LIBERTY 2 placebo-controlled trials, once-daily relugolix combination therapy reduced menstrual blood loss volume and pain in women with heavy menstrual bleeding associated with uterine leiomyomas and was well …

2022
Frontiers in pharmacology ·doi:10.3389/fphar.2022.1045783

Leiomyomas, or uterine fibroids as they are commonly known, are mostly seen in women of reproductive age. However, they can go undetected in most women, and approximately 25% of women show clinical symptoms. Although fibroids are a global b…

review 2021
Journal of women's health (2002) ·doi:10.1089/jwh.2020.8989

Bone mineral density (BMD) changes during the life span, increasing rapidly during adolescence, plateauing in the third decade of life, and subsequently entering a phase of age-related decline. In women, menopause leads to accelerated bone …

review 2021
International journal of molecular sciences ·doi:10.3390/ijms22042165

Cell-cell communication is an essential mechanism for the maintenance and development of various organs, including the female reproductive system. Today, it is well-known that the function of the female reproductive system and successful pr…

review 2021
Nutrients ·doi:10.3390/nu13041178

Diet and nutrition are fundamental in maintaining the general health of populations, including women's health. Health status can be affected by nutrient deficiency and vice versa. Gene-nutrient interactions are important contributors to hea…

2021
F&S science ·doi:10.1016/j.xfss.2020.11.001

Scientists from multiple basic disciplines and an international group of physician-scientists from the field of obstetrics and gynecology presented recent studies and discussed new and evolving theories of uterine fibroid etiology, growth a…

2020
The Journal of clinical endocrinology and metabolism ·doi:10.1210/clinem/dgz227

ContextUterine fibroids (UF) are the most common benign tumor of the myometrium (MM) in women of reproductive age. However, the mechanism underlying the pathogenesis of UF is largely unknown.ObjectiveTo explore the link between nuclear β-ca…

2020
Obstetrics and gynecology ·doi:10.1097/aog.0000000000003869

ObjectiveTo investigate the safety and efficacy of elagolix, an oral gonadotropin-releasing hormone antagonist, with hormonal add-back therapy for up to 12 months in women with heavy menstrual bleeding associated with uterine leiomyomas.Met…

preprint 2020
·doi:10.20944/preprints202009.0421.v1

Female infertility is a global medical condition that can be caused by various disorders of the reproductive system, including premature ovarian failure (POF), polycystic ovary syndrome (PCOS), endometriosis, Asherman syndrome, and preeclam…

review 2020
Cells ·doi:10.3390/cells9102253

Female infertility is a global medical condition that can be caused by various disorders of the reproductive system, including premature ovarian failure (POF), polycystic ovary syndrome (PCOS), endometriosis, Asherman syndrome, and preeclam…

2020
Journal of the Endocrine Society

Abstract Endometriosis and uterine fibroids (leiomyomas) are benign gynecological disorders affecting 5-15% of women of reproductive age. They cause a wide range of symptoms including mild to severe pelvic pain and infertility. Due to a pau…

2020
Journal of Minimally Invasive Gynecology

Study Objective Report baseline Uterine Fibroid Symptoms Quality of Life Questionnaire (UFS-QoL) data from Elaris UF-1 and UF-2 to characterize disease burden from heavy menstrual bleeding (HMB) associated with uterine fibroids (UF). Design…